Clinical Trials at Lancaster General Hospital - Ann B Barshinger Cancer Institute
As of August 2026, 7 paid clinical trials are recruiting at Lancaster General Hospital - Ann B Barshinger Cancer Institute, located at 555 N DUKE ST, LANCASTER, PA 17602-2250, phone (717) 544-5511 in Lancaster, Pennsylvania. Active studies at this site cover conditions such as Heart Failure, Amblyopia and Neoplasm Metastasis. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
7 clinical trials at Lancaster General Hospital - Ann B Barshinger Cancer Institute
·Clear filters·A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Common conditions studied in Lancaster
- Heart Failure (4 active studies)
- Amblyopia (3 active studies)
- Neoplasm Metastasis (3 active studies)
- Non-small Cell Lung Cancer (3 active studies)
- Prostate Cancer (3 active studies)
- Breast Cancer (2 active studies)
Leading research sponsors in Lancaster
- AstraZeneca
- NRG Oncology
- University of Maryland, Baltimore
- Abramson Cancer Center at Penn Medicine
- Bristol-Myers Squibb
Frequently asked questions
How many paid clinical trials are currently recruiting in Lancaster?
There are approximately 70 recruiting clinical trials in Lancaster, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lancaster pay participants?
Most recruiting trials in Lancaster compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lancaster?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lancaster?
The most common conditions under active study in Lancaster include Heart Failure (4), Amblyopia (3), Neoplasm Metastasis (3), Non-small Cell Lung Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lancaster?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lancaster on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lancaster?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lancaster?
Recruiting research sites in Lancaster include Lancaster General Hospital, Keystone Urology Specialists, Lancaster General Hospital - Ann B Barshinger Cancer Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lancaster right now?
The largest active categories in Lancaster are Cancer & tumors (32), Cardiovascular (9), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Lancaster General Hospital - Ann B Barshinger Cancer Institute?
Lancaster General Hospital - Ann B Barshinger Cancer Institute is located at 555 N DUKE ST, LANCASTER, PA 17602-2250. Use the Google Maps link in the intro above to get directions.
How do I contact Lancaster General Hospital - Ann B Barshinger Cancer Institute?
You can reach Lancaster General Hospital - Ann B Barshinger Cancer Institute by phone at (717) 544-5511. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.